Bluejay Diagnostics, Inc. (BJDX) stock
BJDXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$2.15−0.14 (-5.90%)
Close on Nov 17, 2026Market cap $9.63MP/E –Yield –
Bluejay Diagnostics r&d expenses
Research and development expenses are spending on new products and technology.
Bluejay Diagnostics's R&D Expenses for the twelve months ending Jun 30, 2026 was $3.62M, up 30.2% year over year. For fiscal 2025 it was $3.05M, down 12.2% from the year before. The highest annual figure on record is $5.71M in fiscal 2023.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.05M | -12.2% |
| FY2024 | Dec 31, 2024 | $3.47M | -39.2% |
| FY2023 | Dec 31, 2023 | $5.71M | +37.6% |
| FY2022 | Dec 31, 2022 | $4.15M | +261.7% |
| FY2021 | Dec 31, 2021 | $1.15M | +117.7% |
| FY2020 | Dec 31, 2020 | $527.25K | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.44M | +61.6% |
| Q1 FY2026 | Mar 31, 2026 | $811.84K | +3.4% |
| Q4 FY2025 | Dec 31, 2025 | $586.14K | +5.8% |
| Q3 FY2025 | Sep 30, 2025 | $785.61K | +42.4% |
| Q2 FY2025 | Jun 30, 2025 | $889.90K | -13.8% |
| Q1 FY2025 | Mar 31, 2025 | $784.80K | -41.2% |
| Q4 FY2024 | Dec 31, 2024 | $554.00K | -56.9% |
| Q3 FY2024 | Sep 30, 2024 | $551.66K | -60.5% |
| Q2 FY2024 | Jun 30, 2024 | $1.03M | -38.4% |
| Q1 FY2024 | Mar 31, 2024 | $1.33M | -1.5% |
| Q4 FY2023 | Dec 31, 2023 | $1.29M | -2.6% |
| Q3 FY2023 | Sep 30, 2023 | $1.40M | +1.3% |
| Q2 FY2023 | Jun 30, 2023 | $1.68M | +121.6% |
| Q1 FY2023 | Mar 31, 2023 | $1.35M | +95.0% |
| Q4 FY2022 | Dec 31, 2022 | $1.32M | +190.3% |
| Q3 FY2022 | Sep 30, 2022 | $1.38M | +211.8% |
| Q2 FY2022 | Jun 30, 2022 | $756.28K | +234.7% |
| Q1 FY2022 | Mar 31, 2022 | $694.76K | +2772.9% |
| Q4 FY2021 | Dec 31, 2021 | $455.25K | +8.6% |
| Q3 FY2021 | Sep 30, 2021 | $442.53K | +16151.5% |
| Q2 FY2021 | Jun 30, 2021 | $225.99K | – |
| Q1 FY2021 | Mar 31, 2021 | $24.18K | – |
| Q4 FY2020 | Dec 31, 2020 | $419.06K | – |
| Q3 FY2020 | Sep 30, 2020 | $2.72K | – |
See a number that looks wrong?